DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7TXP4

Real-time Bid/Ask 01:00:17 2024-06-11 pm EDT
171.78 EUR / 171.86 EUR +0.26% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+1.47%
1 month+0.90%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-11 171.8 +0.24%
24-06-10 171.4 +0.40%
24-06-07 170.7 +0.70%
24-06-06 169.5 +0.06%
24-06-05 169.4 +0.06%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 12:58 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXP
ISINDE000ME7TXP4
Date issued 2024-01-29
Maturity 2024-12-20 (192 Days)
Parity 1 : 1
Emission price 168.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 172.1
Lowest since issue 164.5
Spread 0.08
Spread %0.05%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
239.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.36%
Consensus